34 related articles for article (PubMed ID: 2015415)
1. Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period.
Portale AA; Carpenter TO; Brandi ML; Briot K; Cheong HI; Cohen-Solal M; Crowley R; Jan De Beur S; Eastell R; Imanishi Y; Imel EA; Ing S; Ito N; Javaid M; Kamenicky P; Keen R; Kubota T; Lachmann R; Perwad F; Pitukcheewanont P; Ralston SH; Takeuchi Y; Tanaka H; Weber TJ; Yoo HW; Zhang L; Theodore-Oklota C; Mealiffe M; San Martin J; Insogna K
Calcif Tissue Int; 2019 Sep; 105(3):271-284. PubMed ID: 31165191
[TBL] [Abstract][Full Text] [Related]
2. A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis.
Insogna KL; Briot K; Imel EA; Kamenický P; Ruppe MD; Portale AA; Weber T; Pitukcheewanont P; Cheong HI; Jan de Beur S; Imanishi Y; Ito N; Lachmann RH; Tanaka H; Perwad F; Zhang L; Chen CY; Theodore-Oklota C; Mealiffe M; San Martin J; Carpenter TO;
J Bone Miner Res; 2018 Aug; 33(8):1383-1393. PubMed ID: 29947083
[TBL] [Abstract][Full Text] [Related]
3. Prospective Analysis of Muscle Adiposity in Children With X-linked Hypophosphatemic Rickets vs Control Children.
Nguyen-Khac V; Bonnet-Lebrun A; Linglart A; de Tienda M; Berkenou J; Mannes I; Adamsbaum C; Wicart P; Skalli W
J Endocr Soc; 2022 Oct; 6(12):bvac135. PubMed ID: 36381011
[TBL] [Abstract][Full Text] [Related]
4. Interactions between FGF23 and vitamin D.
Razzaque MS
Endocr Connect; 2022 Oct; 11(10):. PubMed ID: 36040459
[TBL] [Abstract][Full Text] [Related]
5. Disorders of phosphate homeostasis in children, part 2: hypophosphatemic and hyperphosphatemic disorders.
Shore RM
Pediatr Radiol; 2022 Nov; 52(12):2290-2305. PubMed ID: 35536416
[TBL] [Abstract][Full Text] [Related]
6. The Genetic Architecture of High Bone Mass.
Gregson CL; Duncan EL
Front Endocrinol (Lausanne); 2020; 11():595653. PubMed ID: 33193107
[TBL] [Abstract][Full Text] [Related]
7. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.
Haffner D; Emma F; Eastwood DM; Duplan MB; Bacchetta J; Schnabel D; Wicart P; Bockenhauer D; Santos F; Levtchenko E; Harvengt P; Kirchhoff M; Di Rocco F; Chaussain C; Brandi ML; Savendahl L; Briot K; Kamenicky P; Rejnmark L; Linglart A
Nat Rev Nephrol; 2019 Jul; 15(7):435-455. PubMed ID: 31068690
[TBL] [Abstract][Full Text] [Related]
8. X-linked hypophosphatemia and growth.
Fuente R; Gil-Peña H; Claramunt-Taberner D; Hernández O; Fernández-Iglesias A; Alonso-Durán L; Rodríguez-Rubio E; Santos F
Rev Endocr Metab Disord; 2017 Mar; 18(1):107-115. PubMed ID: 28130634
[TBL] [Abstract][Full Text] [Related]
9. Cervical ossification of posterior longitudinal ligament in x-linked hypophosphatemic rickets revealing homogeneously increased vertebral bone density.
Shiba M; Mizuno M; Kuraishi K; Suzuki H
Asian Spine J; 2015 Feb; 9(1):106-9. PubMed ID: 25705343
[TBL] [Abstract][Full Text] [Related]
10. Successful Medical Therapy for Hypophosphatemic Rickets due to Mitochondrial Complex I Deficiency Induced de Toni-Debré-Fanconi Syndrome.
Bowden SA; Patel HP; Beebe A; McBride KL
Case Rep Pediatr; 2013; 2013():354314. PubMed ID: 24386581
[TBL] [Abstract][Full Text] [Related]
11. High bone mineral apparent density in children with X-linked hypophosphatemia.
Beck-Nielsen SS; Brixen K; Gram J; Mølgaard C
Osteoporos Int; 2013 Aug; 24(8):2215-21. PubMed ID: 23389694
[TBL] [Abstract][Full Text] [Related]
12. Clinical practice: diagnostic approach to the rachitic child.
Rajah J; Thandrayen K; Pettifor JM
Eur J Pediatr; 2011 Sep; 170(9):1089-96. PubMed ID: 21833499
[TBL] [Abstract][Full Text] [Related]
13. Bone metabolism and mineralisation after cytotoxic chemotherapy including ifosfamide.
de Schepper J; Hachimi-Idrissi S; Louis O; Maurus R; Otten J
Arch Dis Child; 1994 Oct; 71(4):346-8. PubMed ID: 7979531
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density of the spine and radius shaft in children with X-linked hypophosphatemic rickets (XLH).
Oliveri MB; Cassinelli H; Bergadá C; Mautalen CA
Bone Miner; 1991 Feb; 12(2):91-100. PubMed ID: 2015415
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets.
Colares Neto GP; Pereira RM; Alvarenga JC; Takayama L; Funari MF; Martin RM
Osteoporos Int; 2017 May; 28(5):1685-1692. PubMed ID: 28194480
[TBL] [Abstract][Full Text] [Related]
16. Lumbar and radial bone mineral density in children and adolescents with X-linked hypophosphatemia: evaluation with dual X-ray absorptiometry.
Shore RM; Langman CB; Poznanski AK
Skeletal Radiol; 2000 Feb; 29(2):90-3. PubMed ID: 10741497
[TBL] [Abstract][Full Text] [Related]
17. X-linked hypophosphatemia: skeletal mass in adults assessed by histomorphometry, computed tomography, and absorptiometry.
Reid IR; Murphy WA; Hardy DC; Teitelbaum SL; Bergfeld MA; Whyte MP
Am J Med; 1991 Jan; 90(1):63-9. PubMed ID: 1986592
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of X-rays in the Differential Diagnosis of Hypophosphataemic Rickets.
Martel-Villagrán J; Arias-Medina A; García-Mardones G
Adv Ther; 2020 May; 37(Suppl 2):89-94. PubMed ID: 32236877
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
